INTRODUCTION
Monocytes and macrophages are major immune cells that play critical roles in innate immunity. Specifically, these cells act as a first line of defense against bacterial, fungal or viral infections during host immune responses (1) . Some pro-inflammatory cytokines [e.g., tumor necrosis factor (TNF)-α and interleukin (IL)-1β] and cytotoxic molecules [e.g., nitric oxide (NO) and reactive oxygen species (ROS)] are primary molecules involved in macrophage-mediated innate immune responses (2, 3) . In some cases, however, these cellular defensive systems cause serious damage to the host cells through activation of cytotoxic pathways such as necrosis and apoptosis (4) .
Honokiol [C18H18O2, molecular weight = 266.33] (Fig. 1 ) is the major component isolated from the bark of the roots and stems of various Magnolia species (5) . To date, various pharmacological effects of honokiol, such as neuroprotective, anticancer, cardiotonic, and anti-inflammatory activities have been reported (6) (7) (8) . It is believed that the molecular mechanisms involved in honokiol pharmacology are managed by modulation of a signaling cascade composed of Ras, Raf, the extracellular signal-regulated kinase (ERK), and NF-κB/IκB kinase (IKK) in response to TNF-α or LPS stimulation and via control of the cellular redox system (9, 10) . Although various cellular responses to honokiol treatment have been evaluated, the damage and morphological alteration of cells induced by inflammatory stimuli have not yet been evaluated. Therefore, in this study, we carefully examined the cytoprotective effects of honokiol under the cellular damage conditions induced by various immunogens such as LPS, peptidoglycan (PGN) and zymosan, as well as on the morphological changes observed in over-activated macrophages and monocytes.
RESULTS AND DISCUSSION
We investigated the modulatory effects of honokiol on various cellular responses managed by monocytes and macrophages. The data presented here suggest that honokiol can strongly protect host immune cells from inflammation-mediated cytotoxic conditions (Fig. 2) induced by cytokine production (Fig.  3A ) and NO generation (Fig. 3B ), but not those induced by the release of ROS (Fig. 3C) . Furthermore, this compound also suppressed the morphological changes (Fig. 4A, B ) that occurred in macrophages during LPS or PMA exposure, as well as morphological alteration-relevant phagocytic uptake. http://bmbreports.org BMB reports LPS generates several cytotoxic molecules that have serious impacts on normal cell viability, including TNF-α, ROS and NO (11) . In the present study, LPS treatment led to a decrease in normal RAW264.7 cells of up to 80% (Fig. 2A) . However, the cell death activities of these cytotoxic molecules were significantly abolished by neutralizing antibody to TNF-α, anti-oxidant against ROS, and inhibitor of NO production (Fig.  2B ). As shown in Fig. 2A , honokiol also clearly suppressed LPS-induced cell death in a dose-dependent manner. Based on these results, the mechanism of honokiol-mediated cytoprotection was investigated in terms of the production of TNF-α, NO and ROS. As shown in Fig. 3A (left panel), honokiol significantly suppressed TNF-α production by up to 60% at 20 μM. This inhibitory effect was also observed in the production of other proinflammatory cytokines (IL-1β and IL-6) (Fig. 3A , left panel) and in the case of different stimulatory conditions (Fig. 3A , right panel). These results suggest that honokiol is capable of blocking a common pathway involved in the production of proinflammatory cytokines. Indeed, it has been reported that honokiol suppresses TNF-α production by suppressing a series of activation pathways composed of Akt, IKK, IκBα, and NF-κB, which is a signaling event generally seen under inflammatory conditions (9) .
The iNOS inhibitor, MMA, strongly suppressed LPS-induced cell death, which indicates that NO is the major cytotoxic molecule involved in the blockage of normal cell viability ( Fig.  2A) . It is well known that honokiol suppresses NO production in macrophages (12) . In the present study, we reevaluated the modulatory effect of this compound on various NO productive conditions induced by different NO stimulatory ligands. As previously reported (12) , honokiol suppressed LPS-induced NO production in a dose-dependent manner (Fig. 3B , left panel). Honokiol also led to a significant reduction in the NO production triggered by the other pattern recognition receptor ligands (Fig. 3B , right panel) that was similar to its inhibitory effect on TNF-α production. It has been reported that honokiol blocks iNOS expression at the transcriptional level (9, 13) . Interestingly, honokiol inhibition appears to be lower in the toll like receptor 2 (TLR2)-mediated signaling pathway. As shown in Fig. 3 (right panel), honokiol weakly suppresses NO production by two representative ligands, PGN and Pam3CSK. Honokiol is also known to strongly neutralize the reactivity of radicals (14, 15) . Therefore, we also tested the scavenging effect of honokiol on the generation of ROS. Unlike studies conducted under in vitro conditions (14, 15) , honokiol failed to decrease the reactivity of SNP-derived radicals in RAW264.7 cells (Fig. 3C, left panel) . Conversely, honokiol enhanced radical reactivity by 10%, which indicates that honokiol may be metabolized in the cell to a form with pro-oxidative or lowered anti-oxidative properties. In contrast, α-tocopherol showed inhibitory activity against SNP-induced radical generation (Fig. 3C, right panel) , which suggests that this experiment was conducted properly.
Morphological changes in macrophages and monocytes under activation conditions are critical for adaptation to environmental changes triggered by inflammatory mediators or cytokines (16, 17) . Indeed, flexible changes in morphology are required for activation, differentiation, migration, infiltration and the movement of cells. Since honokiol suppressed functional activation of macrophages via various inflammatory inducers, we evaluated the ability of honokiol to regulate morphological changes in macrophages and monocytes that were induced by LPS and PMA, as well as the surface levels of marker proteins involved in morphological alteration. Interestingly, honokiol strongly suppressed the morphological alteration of these cells. Thus, it blocked LPS-induced changes in RAW264.7 and U937 cells at a concentration of 20 μM (Fig. 4B, left panel) . Additionally, the strong up-regulation of the surface level of CD69 in response to LPS exposure was also diminished remarkably (Fig. 4B , right panel) in response to honokiol treatment, which is in agreement with the results of a previous study (9) conducted to evaluate co-stimulatory molecules (e.g. CD80). http://bmbreports.org 10 6 cells/ml) were incubated with the indicated concentrations of honokiol in the presence or absence of LPS (1 μg/ml) (A) or other stimuli [PGN (10 μg/ml), zymosan (500 μg/ml), curdlan (100 μg/ml), poly (I：C) (20 μg/ml) and Pam3CSK (10 μg/ml)] for 12 h. The secreted levels of cytokines (TNF-α, IL-1β and IL-6) or NO in culture supernatant were determined by ELISA or Griess assay, as described in the Materials and Methods. (C) RAW264.7 cells (1 × 10 6 ) were pretreated with various concentrations of honokiol or α-tocopherol in the presence or absence of SNP (100 μM) for 30 min. The level of generated ROS was then determined by flow cytometric analysis as described in the Materials and Methods. ## P ＜ 0.01 represents a significant difference as compared to normal. *P ＜ 0.05 and **P ＜ 0.01 represent a significant difference as compared to control.
Furthermore, honokiol treatment also abrogated PMA-induced morphological changes and led to a significant suppression of the levels of CD82 (Fig. 4B, left panel) . Similarly, honokiol strongly inhibited phagocytic uptake of FITC-dextran essentially accompanying the morphological change. Taken together, these results imply that honokiol can modulate the cellular responses involved in morphological changes. Because the actin cytoskeleton is known to play a critical role in regulation of flexible changes in cell morphology (18) , cytoskeleton rearrangement requires further examination to determine if honokiol is able to directly regulate actin.
In conclusion, we report here that honokiol can block the LPS-induced cytotoxicity of RAW264.7 cells by suppressing the production of cytotoxic molecules such as TNF-α and NO, but not ROS. Moreover, honokiol strongly suppressed the phagocytic uptake of FITC-dextran and morphological changes in RAW264.7 and U937 cells. These findings suggest that honokiol may attenuate additional inflammatory responses in-http://bmbreports.org BMB reports 10 5 cells/ml) that had been pretreated with honokiol were stimulated with FITC-dextran (1 mg/ml) for 6 h. The extent of the phagocytic uptake was then determined by flow cytometric analysis, as described in the Materials and Methods. ## P ＜ 0.01 represents a significant difference as compared to normal. *P ＜ 0.05 and **P ＜ 0.01 represent a significant difference as compared to control. duced by the inflammation-mediated cell death pathway of macrophages and monocytes and may negatively modulate migration or infiltration into of cells inflamed sites. 
MATERIALS AND METHODS

Materials
Cytokine production
The inhibitory effect of honokiol on TNF-α production was determined as previously described (19) . Briefly, honokiol was solubilized with vehicle (100% ethanol) and then diluted with RPMI1640. Next, RAW264.7 cells (2 × 10 6 cells/ml) were incubated with LPS (2.5 μg/ml) in the presence or absence of honokiol for 6 h. Supernatants were assayed for the levels of TNF-α, IL-1β and IL-6 using mouse ELISA kits (Amersham, Little Chalfont, Buckinghamshire, UK).
NO assay
RAW 264.7 cells were preincubated with or without honokiol for 30 min and then continuously activated with LPS (2.5 μg/ml) for 24 h. Nitrite determination was conducted using Griess reagent (20) . The absorbance of the product dye was measured at 540 nm using a flow-through spectrophotometer.
MTT assay
Cell proliferation was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay as previously described (19) .
ROS determination
The level of intracellular ROS was determined based on the change in fluorescence resulting from oxidation of the fluorescent probe, DHR123 (21) . Briefly, 5 × 10 5 cells/well were incubated with honokiol for 30 min and then with SNP (125 μM) for an additional 6 h. After a final incubation with 2.5 μM DHR123 for 1 h, the intracellular ROS level was determined using flow cytometry.
Phagocytic uptake
To measure the phagocytic activity of RAW264.7 cells, a previously reported method was used, with slight modification (22) . Briefly, RAW 264.7 cells (1 × 10 6 cells/ml) were preincubated with or without honokiol for 30 min, and then further incubated for 6 h. Finally, the cells were incubated with FITC-dextran (1 mg/ml) for 30 min at 37 o C. The reaction was then stopped by addition of 2 ml of ice-cold PBS, after which the cells were washed four times with cold PBS. After fixing the cells with 3.7% formaldehyde, phagocytic uptake was analyzed using a FACScan device (Becton-Dickinson, San Jose, CA, USA).
Flow cytometric analysis
Surface levels of CD69 and CD82 on U937 or RAW264.7 cells were determined by flow cytometric analysis using a previously described method (23) . Stained cells were analyzed on a FACScan device (Becton-Dickinson, San Jose, Calif., USA).
Statistical analysis
A student's t-test and one-way ANOVA were used to determine the statistical significance of differences between the experimental and control groups. P values of 0.05 or less were considered to be statistically significant.
